VAKCINA

rumbeando wrote:Kažu tamo da Kinez opet može mimo prijave, ovaj put na KBC Zvezdara, vakcinisali se ljudi juče i danas.

Biljana Tasic @bilja_gypsy

Moje iskustvo sa imunizacije. Bila sam u domu zdravlja Rakovica, Oplenacka 40. Pustali su ljude koji nisu zakazani, ali im su ih poslala Slavica i Sneza, ko god one bile. Ne znam zasto se prijavljujemo onda preko e uprave.
3:34 PM · Feb 17, 2021·Twitter Web App

Sestra koja je bila na ulazu primala je ljude koji su bili posle mene zakazani, vise puta sam rekla da sam zakazana u odredjeno vreme, pre njih, pravila se da me ne cuje.

Takodje, sam je zamolila da mi da papir da ispunim formular, ona nije uopste obratila paznju na mene, dodatno sam cekala 10 minuta ispred ordinacije, da bi mi rekli da moram da popunim formular.

Kada su je kolege pitale zasto mi nije dala formular i pustila na vreme, ona je odmahnula rukom, nesto tipa "Ma, pusti Ciganka".

Nismo isti, niti ravnopravni, cak ni kod lekara. Gde bi trebalo da budemo. Naravno da cu da pidnesem i zvanicnu prijavu.

Jos nesto, bila sam sa mamom u subotu i ona je pitala da li mogu i ja da primim vakcinu, iako nemam zakazano, rekli su da ne moze, a danas su pustali na moje oci, mnostvo ljudi koje nemaju zakazano
Cc  @eUprava

Đerlek: Danas ćemo premašiti broj od milion datih doza vakcina, radi i Belekspo https://t.co/8VSOQbCgC6

— TV N1 Beograd (@N1infoBG) February 17, 2021

rumbeando wrote:

Komsinica se posle prve doze vakcine opustila, vecere, druzenje. Eno je u bolnici, ca covidom.

— Srdjan Dragojevic (@srdjandrago) February 17, 2021

Kao ovaj liflet naprimer pic.twitter.com/ftec2QqT0z

— Yadranka’s (@s_yadranka) February 17, 2021

Mór Thököly wrote:Sa revakcinama

Brussels is set to almost triple its orders of Moderna’s coronavirus vaccine as part of an EU push to respond to the emergence of new variants and the possible need for booster shots.
The European Commission and Moderna on Wednesday announced a deal for a further 150m doses of the US pharmaceutical company’s jab this year, and an option for 150m more next year. Next year’s order could be of a vaccine tailored to a new variant, if necessary, one person familiar with the matter said. 
The agreement, first reported by the Financial Times, would add to Brussels’ agreement last year to buy 160m Moderna shots. It is part of a wider effort to tackle criticism of the EU’s sluggish vaccine rollout and prepare for the possible evolution of the disease as mutant strains appear. 
Stella Kyriakides, the European commissioner for health and food safety, said the contract was key not only for the current vaccine rollout but also to limit the spread of variants future.
BioNTech/Pfizer has also confirmed an agreement previously flagged by Brussels to increase supplies of its vaccine to the EU expected this year from 300m doses to 500m, with the option to add 100m more. 
Deliveries under the new Moderna deal are unlikely to ease the current short-term vaccine supply squeeze ahead of an increase in deliveries to the EU in April. BioNTech said an estimated 75m of the additional 200m doses it had agreed would be delivered between April and June. 
The development comes as Ursula von der Leyen, commission president, steps up her efforts to boost the EU’s vaccine supplies following weeks of negative headlines over the rollout. 

RDIF told the FT that it had signed contracts with 15 manufacturers in 10 countries to produce 1.4bn [Sputnik V] jabs, enough to vaccinate 700m people.
The agreements mean RDIF is relying on foreign plants to produce more than twice as many doses as Russian companies. Factories in China, South Korea, India and Iran will manufacture shots that could be exported to third countries, while plants in states such as Brazil and Serbia will primarily serve domestic demand.
We have some players who are really big, and they will be producing for the whole world. And we have some who are smaller and they will be producing more for local demand,” said Kirill Dmitriev, RDIF’s head. “This is our approach: to solve the bigger production issue while also providing local availability.”
RDIF is banking on that devolved approach to help it avoid the production shortfalls that have bedevilled other Covid-19 vaccine producers such as AstraZeneca, while also tapping a large market for jabs in poorer countries.
Russian state TV proclaimed in November last year that the two-shot adenovirus-based vaccine was “as simple and reliable as the Kalashnikov assault rifle”. Yet experts in many western countries were sceptical in the absence of peer-reviewed evidence.
But after a study published earlier this month said the vaccine was 91.6 per cent effective — on a par with mRNA vaccines from BioNTech/Pfizer and Moderna — Sputnik V is now seeking to emulate the Kalashnikov as one of Russia’s great exports. 

Александар Карађорђевић[/url]
 

Berlin -- Predsednica Evropske komisije Ursula fon der Lajen izrazila je danas čuđenje ruskom politikom vakcinacije i ponudom isporuke svoje vakcine drugim zemljama.
Istakla je da se postavlja pitanje zašto Moskva drugim zemljama teoretski nudi milione doza vakcine "Sputnjik V", a zaostaje u vakcinisanju sopstvenog stanovništva.

"To je pitanje na koje treba da daju odgovor", poručila je ona.

Fon der Lajen je kazala i da Evropskoj agenciji za lekove još nije podnet nikakav zahtev za uslovno odobrenje "Sputnjika V".

Erős Pista wrote:Prati Zileta na tvici.